| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/18/1992 | EP0475478A1 Haemophilus paragallinarum vaccine |
| 03/18/1992 | EP0475409A2 Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions |
| 03/18/1992 | EP0475182A2 Method for protein synthesis using CKS fusion proteins |
| 03/18/1992 | EP0474891A1 Vectors for expression of malarial antigens on the surface of Salmonella vaccine strains |
| 03/18/1992 | EP0474868A1 Method of producing core structure of retro virus and particle produced thereby |
| 03/18/1992 | EP0474846A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides. |
| 03/18/1992 | EP0474783A1 Vpt protein, vectors expressing this protein, cell products and assay methods |
| 03/18/1992 | EP0474764A1 Method to treat rheumatoid arthritis |
| 03/18/1992 | EP0474676A1 Production of ibdv vp2 in highly immunogenic form |
| 03/18/1992 | EP0474646A1 Bordetella vaccines |
| 03/18/1992 | EP0474645A1 Protein complex |
| 03/18/1992 | CN1059471A Heamophilus paragallinarum vaccine |
| 03/18/1992 | CA2090673A1 Vaccine compositions |
| 03/18/1992 | CA2048089A1 Chemical conjugation of morpholino anthracyclines to antibodies |
| 03/17/1992 | US5097020 Immunogenic conjugates |
| 03/17/1992 | US5097018 Sequential heat treatment of blood-clotting factor products |
| 03/17/1992 | US5096838 Fluorescent tracers for detection of barbiturates and for antiserums |
| 03/17/1992 | US5096706 Antigen-based treatment for adiposity |
| 03/17/1992 | US5096703 Administering aminoguanidine or its salts; oral rinse, tooth paste |
| 03/17/1992 | CA1297437C Process for the preparation of protease inhibitors |
| 03/17/1992 | CA1297407C Pharmaceutical which can be administered nasally, a process for it preparation, and its use |
| 03/15/1992 | WO1992004908A1 Drug containing cd14 |
| 03/15/1992 | CA2072626A1 Drug containing cd14 |
| 03/12/1992 | WO1992004381A1 Novel antibodies for treatment and prevention of infection in animals and man |
| 03/12/1992 | CA2091335A1 Antibodies for treatment and prevention of infection in animals and man |
| 03/11/1992 | EP0474313A2 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations |
| 03/11/1992 | EP0473725A1 Composition and method to detect sensitivity to alpha interferon therapy |
| 03/11/1992 | EP0473721A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 03/11/1992 | EP0238657B1 Antiviral immunotherapeutic agent and preparation thereof |
| 03/11/1992 | CN1059279A Liposomes that provide thymic dependent help to weak vaccine antigens |
| 03/11/1992 | CN1059278A 抗体共轭物 Antibody conjugate |
| 03/10/1992 | US5095097 Diagnostics |
| 03/10/1992 | US5095096 Fused protein comprising lymphotoxin |
| 03/10/1992 | US5095094 A43 kDa antigenic protein of Bordetella recognized by polyclonal antibodies to adenylate cyclase but devoid of calmodulin-activatable adenylate cyclase activity |
| 03/10/1992 | US5095093 Protective four amino acid epitope against Plasmodium vivax malaria |
| 03/10/1992 | US5094949 Side effect reduction |
| 03/10/1992 | US5094850 Deactivation of virus |
| 03/10/1992 | CA1297049C Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein |
| 03/10/1992 | CA1297003C Composition and method for treating animals |
| 03/09/1992 | CA2050876A1 Recombinant expression vectors capable of expressing immunogenic malarial antigens on the surface of salmonella vaccine strains |
| 03/08/1992 | CA2050850A1 Recombinant herpes viruses, a vaccine based on these recombinants, their preparation process, genes, vectors and plasmids used in this process |
| 03/07/1992 | WO1992004049A1 Inhibitor of lymphocyte response and immune-related disease |
| 03/07/1992 | CA2071896A1 Inhibitor of lymphocyte response and immune-related disease |
| 03/06/1992 | CA2049129A1 Haemophilus paragallinarum vaccine |
| 03/05/1992 | WO1992004463A1 Cd58-specific monoclonal antibodies and their use |
| 03/05/1992 | WO1992004015A2 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 03/05/1992 | WO1992004014A2 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 03/05/1992 | WO1992003733A1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 03/05/1992 | WO1992003569A1 Protein polyligands joined to a stable protein core |
| 03/05/1992 | WO1992003558A1 Interleukin-2-leukotoxin gene fusions and uses thereof |
| 03/05/1992 | WO1992003554A1 Infectious laryngotracheitis virus vaccine |
| 03/05/1992 | WO1992003553A1 Footrot vaccine |
| 03/05/1992 | WO1992003552A1 P. falciparum-infected red corpuscles and immunogenic compositions containing same |
| 03/05/1992 | WO1992003550A1 Ryegrass pollen allergen |
| 03/05/1992 | WO1992003549A1 Specific dna sequences of a nematode which can be used for the diagnosis of infection with the nematode |
| 03/05/1992 | WO1992003548A1 Human zona pellucida protein zp3 |
| 03/05/1992 | WO1992003545A1 Flavivirus recombinant poxvirus vaccine |
| 03/05/1992 | WO1992003537A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | WO1992003475A1 Enterovirus peptides |
| 03/05/1992 | WO1992003467A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/05/1992 | WO1992003457A1 Entamoeba histolytica immunodominant surface antigens |
| 03/05/1992 | WO1992003165A1 New use of a monoclonal antibody |
| 03/05/1992 | WO1992003164A1 Neuraminidase and galactose oxidase as vaccine adjuvant |
| 03/05/1992 | WO1992003163A1 Vaccine and immunoserum against drugs of abuse |
| 03/05/1992 | WO1992003162A1 Vaccines |
| 03/05/1992 | WO1992003161A1 Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection |
| 03/05/1992 | WO1992003160A1 Papua new guinea human t-lymphotropic virus |
| 03/05/1992 | WO1992003157A1 Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof |
| 03/05/1992 | WO1992003156A1 Membrane-derived antiflea vaccines |
| 03/05/1992 | WO1991015516A3 Hepatitis c virus epitopes |
| 03/05/1992 | CA2090689A1 Regulation of t-cell proliferation via a novel 5htla receptor |
| 03/05/1992 | CA2090688A1 Regulation of neoplastic cell proliferation via a novel 5htla receptor |
| 03/05/1992 | CA2090105A1 Protein polyligands joined to a stable protein core |
| 03/05/1992 | CA2089497A1 Self-assembling replication defective hybrid virus particles |
| 03/05/1992 | CA2081770A1 A cd58-specific monoclonal antibody and the use thereof |
| 03/04/1992 | EP0473210A2 Recombinant Marek's disease virus |
| 03/04/1992 | EP0473111A2 Recombinant mite allergen |
| 03/04/1992 | EP0328542B1 Antiparathyroid antibody preparation |
| 03/03/1992 | US5093475 Hindered linking agents derived from 2-iminothiolanes and methods |
| 03/03/1992 | US5093321 Dialysates for treating aids and arc and for otherwise increasing immune response |
| 03/03/1992 | US5093318 Immunostimulating guanosine derivatives and their pharmaceutical compositions |
| 03/03/1992 | US5093261 Monoclonal antibodies |
| 03/03/1992 | US5093258 For expressing immunogenic proteins, poultry vaccines |
| 03/03/1992 | US5093241 C-terminal cat fusion protein and process of preparation by recombinant dna |
| 03/03/1992 | US5093118 Antigen of Blastomyces dermatitidis and its uses |
| 03/03/1992 | US5093117 Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
| 03/03/1992 | CA1296662C Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 03/03/1992 | CA1296660C Monoclonal antibody against a ras oncogene p21 related dodecapeptide |
| 03/03/1992 | CA1296624C Microspheric bodies and method for detecting therapies of alzheimer's diseaseand related conditions |
| 03/03/1992 | CA1296623C Aids prognosis test |
| 03/01/1992 | WO1992005760A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome |
| 03/01/1992 | WO1992004377A1 HUMAN INTERFERON-η4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS |
| 03/01/1992 | WO1992004341A1 Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes |
| 03/01/1992 | WO1992004053A1 Homoconjugated immunoglobulins |
| 03/01/1992 | WO1992004048A2 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 03/01/1992 | WO1992004047A1 Methods of treating, diagnosing and monitoring therapies from levels of human oubain-like factor and antibody thereof |
| 03/01/1992 | WO1992004046A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 03/01/1992 | WO1992004034A1 Method for treating endotoxin shock using anti-adhesion antibodies |
| 03/01/1992 | WO1992003152A1 New insulin-like growth factor binding protein (igfbp-4) |
| 03/01/1992 | CA2090703A1 Insulin-like growth factor binding protein (igfbp-4) |